AtriCure, Inc.
ATRC · XNASCIK 1323885fmd_15VR0V8MSYY8HN5EK2DRAGN4TAManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 155 | 175 | 202 | 231 | 207 | 274 | 330 | 399 | 465 | 535 |
| Cost of revenue | 44 | 49 | 55 | 60 | 57 | 68 | 84 | 99 | 118 | 134 |
| Net interest income | – | – | 3 | – | – | – | – | – | – | – |
| Gross profit | 111 | 126 | 147 | 170 | 149 | 206 | 246 | 300 | 348 | 401 |
| Realized investment gains (losses) | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | 36 | 34 | 35 | 41 | 43 | 49 | 57 | 74 | 96 | 99 |
| Selling, general and administrative | 106 | 117 | 130 | 167 | 151 | 205 | 231 | 253 | 291 | 311 |
| Total operating expenses | 142 | 151 | 164 | 203 | 194 | 151 | 289 | 327 | 388 | 410 |
| Operating income | (31) | (25) | (17) | (33) | (44) | 55 | (43) | (27) | (40) | (9) |
| Interest expense | 2 | 2 | 5 | 4 | 5 | 5 | 5 | 7 | 6 | 6 |
| Interest and investment income | 0 | 0 | 1 | 2 | 1 | 0 | 2 | 4 | 4 | 4 |
| Other non-operating income (expense) | (1) | 0 | (0) | (0) | (0) | (0) | (1) | (0) | (0) | 1 |
| Income before taxes | (33) | (27) | (21) | (35) | (48) | 50 | (46) | (30) | (44) | (10) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Net income from continuing operations | (33) | (27) | (21) | (35) | (48) | 50 | (46) | (30) | (45) | (11) |
| Net income | (33) | (27) | (21) | (35) | (48) | 50 | (46) | (30) | (45) | (11) |